Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset

Collongues, N.; Marignier, R.; Jacob, A.; Leite, M.; Sivas, A.; Paul, F.; Zephir, H.; Akman-Demirs, G.; Elsone, L.; Jarius, S.; Papeix, C.; Mutch, K.; Saips, S.; Wildemann, B.; Kitley, J.; Karabudak, R.; Aktas, O.; Kuscu, D.; Altintas, A.; Palace, J.; Confavreux, C.; De Seze, J.

doi:10.1177/1352458513515085

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset

Copy For Citation

Collongues N., Marignier R., Jacob A., Leite M. I., Sivas A., Paul F., ...More

MULTIPLE SCLEROSIS JOURNAL, vol.20, no.8, pp.1086-1094, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 20 Issue: 8
Publication Date: 2014
Doi Number: 10.1177/1352458513515085
Journal Name: MULTIPLE SCLEROSIS JOURNAL
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1086-1094
Istanbul University Affiliated: Yes

Abstract

Background: Few data are available for patients with a late onset (>= 50 years) of neuromyelitis optica (LONMO) or neuromyelitis optica spectrum disease (LONMOSD), defined by an optic neuritis/longitudinally extensive transverse myelitis with aquaporin-4 antibodies (AQP4-Ab).